sunvozertinib
dizal pharmaceuticals
['sunvozertinib', 'sclc', 'lcsm,(-blcsm)', 'nsclc']
sunvozertinib demonstrates antitumor activity and tolerability in egfr exon 20 mutated nsclc #asco23 #asco2023 #lcsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.